Literature DB >> 8589220

A new method to explore the distribution of interindividual random effects in non-linear mixed effects models.

K E Fattinger1, L B Sheiner, D Verotta.   

Abstract

This article presents a new approach for exploring the distribution of interindividual random effects in nonlinear mixed effect models. The approach introduces a spline function, which transforms an assumed normally distributed interindividual random effect to an arbitrary distribution approximating that of the data. The performance of this tool is illustrated using simulated pharmacokinetic data with non-normally distributed random effects. Results of the analyses of two real kinetic data sets are also presented.

Mesh:

Substances:

Year:  1995        PMID: 8589220

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Statistical issues in multisite effectiveness trials: the case of brief strategic family therapy for adolescent drug abuse treatment.

Authors:  Daniel J Feaster; Michael S Robbins; Viviana Horigian; José Szapocznik
Journal:  Clin Trials       Date:  2004       Impact factor: 2.486

2.  A new approach to modeling covariate effects and individualization in population pharmacokinetics-pharmacodynamics.

Authors:  Tze Leung Lai; Mei-Chiung Shih; Samuel P Wong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-10       Impact factor: 2.745

3.  Semiparametric distributions with estimated shape parameters.

Authors:  Klas J F Petersson; Eva Hanze; Radojka M Savic; Mats O Karlsson
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

Review 4.  Population pharmacokinetics. A regulatory perspective.

Authors:  H Sun; E O Fadiran; C D Jones; L Lesko; S M Huang; K Higgins; C Hu; S Machado; S Maldonado; R Williams; M Hossain; E I Ette
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

5.  A use of Monte Carlo integration for population pharmacokinetics with multivariate population distribution.

Authors:  A Yafune; M Takebe; H Ogata
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

6.  A nonparametric subject-specific population method for deconvolution: II. External validation.

Authors:  K E Fattinger; D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

7.  A semiparametric method for describing noisy population pharmacokinetic data.

Authors:  K Park; D Verotta; T F Blaschke; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

8.  Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelix.

Authors:  Christoffer W Tornøe; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

9.  Mixed effects modeling of weight change associated with placebo and pregabalin administration.

Authors:  Bill Frame; Stuart L Beal; Raymond Miller; Jeannette Barrett; Paula Burger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-08-10       Impact factor: 2.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.